Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Ahmad Awada, MD, PhD, of the Jules Bordet Cancer Institute, Brussels, Belgium, explains the immunotherapy future that is on the horizon. Speaking at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL, Prof. Awada goes on to discuss the treatment of patients that are HIV-positive with checkpoint-inhibitors.
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.